Commentary Open Access
Volume 3 | Issue 2 | DOI: https://doi.org/10.33696/AIDS.3.019

Fostemsavir in Heavily Treatment-Experienced Individuals Living with HIV-1: Insights from the Phase 3 BRIGHTE Study

  • 1ViiV Healthcare, Branford, CT, USA
  • 2ViiV Healthcare, Brussels, Belgium
  • 3ViiV Healthcare, Brentford, UK
  • 4Yale University School of Medicine, New Haven, CT, USA
+ Affiliations - Affiliations

Corresponding Author

 Max Lataillade, max.x.lataillade@viivhealthcare.com

Received Date: March 23, 2021

Accepted Date: June 21, 2021

Author Information X